West to Host Fourth-Quarter and Full-Year 2024 Conference Call

Rhea-AI Summary

West Pharmaceutical Services (NYSE: WST) has announced its upcoming fourth-quarter and full-year 2024 financial results release, scheduled for Thursday, February 13, 2025, before market opening. The company will host a conference call at 9:00 a.m. Eastern Time to discuss the results and business expectations.

Interested participants can access the live webcast through the company's Investor Relations website. To participate in the Q&A session, advance registration is required, after which participants will receive dial-in details and a unique PIN. A slide presentation will be available in the Investors section on the day of the call. The webcast replay will be accessible for approximately 90 days following the event.

News Market Reaction

+1.28%

1 alert

+1.28% News Effect

On the day this news was published, WST gained 1.28%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

EXTON, Pa., Jan. 30, 2025  /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST),  global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2024 financial results before the market opens on Thursday, February 13, 2025, and will follow with a conference call to discuss the results and business expectations at 9:00 a.m. Eastern Time.

The live webcast will be made available via the Company's Investor Relations website or by clicking here.

To ask questions on the conference call, participants need to register in advance by clicking here.  Registered telephone participants will receive the dial-in number along with a unique PIN number that will enable them to ask questions on the call. 

A slide presentation will be made available on the day of the call in the Investors section of the Company's website. A replay of the conference call and webcast will be available on the Company's website.  Replay of the webcasts will be available for approximately 90 days after the events.

About West  

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.  

Headquartered in Exton, Pennsylvania, West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-host-fourth-quarter-and-full-year-2024-conference-call-302363473.html

SOURCE West Pharmaceutical Services, Inc.

FAQ

When will West Pharmaceutical Services (WST) release its Q4 and full-year 2024 earnings?

West Pharmaceutical Services will release its Q4 and full-year 2024 earnings before the market opens on Thursday, February 13, 2025.

What time is WST's Q4 2024 earnings conference call?

The earnings conference call is scheduled for 9:00 a.m. Eastern Time on February 13, 2025.

How can investors participate in WST's Q4 2024 earnings call?

Investors can participate by accessing the live webcast through the company's Investor Relations website. To ask questions, participants must register in advance to receive dial-in details and a unique PIN.

How long will WST's Q4 2024 earnings call replay be available?

The webcast replay will be available for approximately 90 days after the event on the company's website.